CIK: 0001056807
申告総資産額
$31.4億
| # | ティッカー | 発行体 | 資産子分類 | 比率 | 比率変動 | 持株数変化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ARRYEUR | Array Biopharma INC | 株式-その他 | 13.40% | — | +35.67% | |
| 2 | ANAB | Anaptysbio INC | 株式-その他 | 7.22% | — | -56.90% | |
| 3 | 2655787D | Blueprint Medicines CORP | 株式-その他 | 6.98% | — | -23.82% | |
| 4 | XOMA | Xoma Royalty Corporation | 株式-その他 | 6.45% | +0.27% | — | |
| 5 | CNCEEUR | Concert Pharmaceuticals INC | 株式-その他 | 6.14% | — | -37.17% | |
| 6 | CYTK | Cytokinetics INC | 株式-ヘルスケア | 5.62% | — | +361.06% | |
| 7 | CCXIEUR | Chemocentryx INC | 株式-その他 | 5.44% | — | — | |
| 8 | ✓ | Biolinerx Ltd-spons Adr | 株式-その他 | 3.42% | — | — | |
| 9 | SNDX | Syndax Pharmaceuticals INC | 株式-その他 | 3.41% | — | — | |
| 10 | ARQLUSD | Arqule INC | 株式-その他 | 3.27% | — | +122.12% | |
| 11 | CTMX | Cytomx Therapeutics INC | 株式-その他 | 2.86% | — | -49.60% | |
| 12 | CTIC1USD | Cti Biopharma CORP | 株式-その他 | 2.78% | — | — | |
| 13 | KURA | Kura Oncology INC | 株式-その他 | 2.50% | -0.82% | — | |
| 14 | INFIQ | Infinity Pharmaceuticals INC | 株式-その他 | 2.39% | — | +24.16% | |
| 15 | PIRSEUR | Pieris Pharmaceuticals INC | 株式-その他 | 2.39% | — | -12.15% | |
| 16 | ✓ | Oncomed Pharmaceuticals INC | 株式-その他 | 2.11% | — | -2.93% | |
| 17 | ✓ | Regulus Therapeutics INC | 株式-その他 | 1.75% | — | +7.92% | |
| 18 | ✓ | Gtx INC Del | 株式-その他 | 1.70% | — | -0.09% | |
| 19 | ERYP1EUR | Erytech Pharma - Spon Adr | 株式-その他 | 1.66% | — | — | |
| 20 | VAC2USD | Vbi Vaccines INC | 株式-その他 | 1.60% | — | — | |
| 21 | FWRD | Forward Air Corporation | 株式-その他 | 1.52% | — | +137.45% | |
| 22 | SPRO | Spero Therapeutics INC | 株式-その他 | 1.46% | — | — | |
| 23 | ✓ | Cascadian Therapeutics | 株式-その他 | 1.40% | — | — | |
| 24 | SBPHUSD | Spring Bank Pharmaceuticals | 株式-その他 | 1.34% | — | +26.17% | |
| 25 | XENE | Xenon Pharmaceuticals INC | 株式-その他 | 1.22% | — | — | |
| 26 | GLYCEUR | Glycomimetics INC | 株式-その他 | 1.01% | — | -84.60% | |
| 27 | NVLSEUR | Alpine Immune Sciences INC | 株式-その他 | 0.91% | — | — | |
| 28 | SNSSEUR | Viracta Therapeutics INC | 株式-その他 | 0.91% | — | — | |
| 29 | ✓ | Molecular Templates Inc | 株式-その他 | 0.87% | — | — | |
| 30 | ✓ | Veralto CORP | 株式-その他 | 0.83% | — | — | |
| 31 | PTGX | Protagonist Therapeutics INC | 株式-その他 | 0.74% | — | — | |
| 32 | IMRX | Immuneering Corporation | 株式-その他 | 0.69% | — | — | |
| 33 | ✓ | Tocagen INC | 株式-その他 | 0.69% | — | -47.63% | |
| 34 | CRVS | Corvus Pharmaceuticals INC | 株式-その他 | 0.57% | — | — | |
| 35 | ACHNEUR | Achillion Pharmaceuticals | 株式-その他 | 0.56% | — | — | |
| 36 | ITCIEUR | Intra-cellular Therapies INC | 株式-その他 | 0.48% | — | -71.23% | |
| 37 | OREXQ 2.75 12-01-20 | Orexigen Therapeutics In | 株式-その他 | 0.43% | — | — | |
| 38 | CFRXEUR | Contrafect CORP | 株式-その他 | 0.43% | — | — | |
| 39 | ✓ | Vical INC Com New | 株式-その他 | 0.31% | — | — | |
| 40 | ANTH | Anthera Pharmaceuticals INC | 株式-その他 | 0.24% | — | +20.85% | |
| 41 | ✓ | Pain Therapeutics INC | 株式-その他 | 0.16% | — | +0.00% | |
| 42 | ✓ | Orexigen Therapeutics INC Com New | 株式-その他 | 0.11% | — | — | |
| 43 | ✓ | Loxo Oncology INC | 株式-その他 | 0.04% | — | -98.16% |
| # | ティッカー | 発行体 | 比率変動 | 持株数変化 | アクション |
|---|---|---|---|---|---|
| 1 | ARRYEUR | Array Biopharma INC | +3.4% | +35.67% | 増加 |
| 2 | CYTK | Cytokinetics INC | +3.3% | +361.06% | 増加 |
| 3 | XOMA | Xoma Royalty Corporation | +2.7% | — | 変化なし |
| 4 | ARQLUSD | Arqule INC | +2.2% | +122.12% | 増加 |
| 5 | ANAB | Anaptysbio INC | +1.1% | -56.90% | 減少 |
| 6 | INFIQ | Infinity Pharmaceuticals INC | +1.1% | +24.16% | 増加 |
| 7 | ✓ | Gtx INC Del | +0.5% | -0.09% | 減少 |
| 8 | FWRD | Forward Air Corporation | +0.4% | +137.45% | 増加 |
| 9 | SNSSEUR | Viracta Therapeutics INC | +0.4% | — | 変化なし |
| 10 | CNCEEUR | Concert Pharmaceuticals INC | +0.3% | -37.17% | 減少 |
| 11 | ✓ | Molecular Templates Inc | +0.2% | — | 変化なし |
| 12 | PIRSEUR | Pieris Pharmaceuticals INC | +0.2% | -12.15% | 減少 |
| 13 | ANTH | Anthera Pharmaceuticals INC | +0.1% | +20.85% | 増加 |
| 14 | ✓ | Pain Therapeutics INC | 0% | +0.00% | 増加 |
| 15 | CFRXEUR | Contrafect CORP | -0.1% | — | 変化なし |
| 16 | SBPHUSD | Spring Bank Pharmaceuticals | -0.1% | +26.17% | 増加 |
| 17 | KURA | Kura Oncology INC | -0.1% | — | 変化なし |
| 18 | ✓ | Orexigen Therapeutics INC Com New | -0.1% | — | 変化なし |
| 19 | NVLSEUR | Alpine Immune Sciences INC | -0.1% | — | 変化なし |
| 20 | XENE | Xenon Pharmaceuticals INC | -0.1% | — | 変化なし |
| 21 | OREXQ 2.75 12-01-20 | Orexigen Therapeutics In | -0.2% | — | 変化なし |
| 22 | ✓ | Cascadian Therapeutics | -0.2% | — | 変化なし |
| 23 | ✓ | Biolinerx Ltd-spons Adr | -0.3% | — | 変化なし |
| 24 | ✓ | Regulus Therapeutics INC | -0.3% | +7.92% | 増加 |
| 25 | CRVS | Corvus Pharmaceuticals INC | -0.4% | — | 変化なし |
| 26 | ✓ | Oncomed Pharmaceuticals INC | -0.4% | -2.93% | 減少 |
| 27 | CTIC1USD | Cti Biopharma CORP | -0.7% | — | 変化なし |
| 28 | ✓ | Tocagen INC | -1% | -47.63% | 減少 |
| 29 | ITCIEUR | Intra-cellular Therapies INC | -1.4% | -71.23% | 減少 |
| 30 | CCXIEUR | Chemocentryx INC | -1.7% | — | 変化なし |
| 31 | 2655787D | Blueprint Medicines CORP | -1.9% | -23.82% | 減少 |
| 32 | CTMX | Cytomx Therapeutics INC | -2.3% | -49.60% | 減少 |
| 33 | ✓ | Loxo Oncology INC | -2.8% | -98.16% | 減少 |
| 34 | GLYCEUR | Glycomimetics INC | -4.7% | -84.60% | 減少 |
| 35 | IRWD | Ironwood Pharmaceuticals INC | — | EXIT | 全売却 |
| 36 | SNDX | Syndax Pharmaceuticals INC | — | NEW | 新規購入 |
| 37 | ✓ | Zealand Pharma A S | — | EXIT | 全売却 |
| 38 | ERYP1EUR | Erytech Pharma - Spon Adr | — | NEW | 新規購入 |
| 39 | VAC2USD | Vbi Vaccines INC | — | NEW | 新規購入 |
| 40 | SPRO | Spero Therapeutics INC | — | NEW | 新規購入 |
| 41 | ✓ | Veralto CORP | — | NEW | 新規購入 |
| 42 | PTGX | Protagonist Therapeutics INC | — | NEW | 新規購入 |
| 43 | IMRX | Immuneering Corporation | — | NEW | 新規購入 |
| 44 | ACHNEUR | Achillion Pharmaceuticals | — | NEW | 新規購入 |
| 45 | ✓ | Vical INC Com New | — | NEW | 新規購入 |
| 46 | ADROEUR | Chinook Therapeutics INC | — | EXIT | 全売却 |